Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
Raloxifene HCl belongs to a class of selective estrogen receptor modulators (SERMs) which is used for the management of breast cancer. The major problem reported with raloxifene is its poor bioavailability which is only up to 2%. The main objective of the present work was to formulate raloxifene loa...
Similar Items
-
Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation
by: Mahmood, Syed, et al.
Published: (2018) -
Advanced characterization of ethanolic nano lipid vesicles loaded with raloxifene HCl for transdermal drug delivery
by: Mahmood, Syed, et al.
Published: (2016) -
Nano transfersomes vesicles of raloxifene HCl with sorbitan 80: formulation and characterization
by: Mahmood, Sayed, et al.
Published: (2018) -
Formulation and optimization of raloxifene loaded nanotransfersomes by response surface methodology for transdermal drug delivery
by: Mandal, Uttam Kumar, et al.
Published: (2014) -
Formulation and optimization of raloxifene loaded nanotransfersomes by response surface methodology for transdermal drug delivery
by: Mahmood, Syed, et al.
Published: (2014)